compound J [PMID: 21907142]   Click here for help

GtoPdb Ligand ID: 7854

Synonyms: Example 1 (WO2011029803)
PDB Ligand
Compound class: Synthetic organic
Comment: First published reports of this compound described it as a BACE1 inhibitor, but it was later identified as a BACE2 inhibitor as example 1 (with IC50 9 nM) from patent WO2011029803 [1]. It is also published as compound J from the BACE2 diabetes target paper [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 105.67
Molecular weight 378.07
XLogP 3
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)C1(C)CCSC(=N1)N)F
Isomeric SMILES Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]1(C)CCSC(=N1)N)F
InChI InChI=1S/C17H16ClFN4OS/c1-17(6-7-25-16(20)23-17)12-8-11(3-4-13(12)19)22-15(24)14-5-2-10(18)9-21-14/h2-5,8-9H,6-7H2,1H3,(H2,20,23)(H,22,24)/t17-/m0/s1
InChI Key VVZZZUNCWSTIOI-KRWDZBQOSA-N
References
1. Beauchamp J et al. (2011)
2 -aminodihydro [1, 3] thiazines as BACE2 inhibitors for the treatment of diabetes.
Patent number: WO2011029803. Assignee: Roche. Priority date: 31/10/2014. Publication date: 17/03/2011.
2. Esterházy D, Stützer I, Wang H, Rechsteiner MP, Beauchamp J, Döbeli H, Hilpert H, Matile H, Prummer M, Schmidt A et al.. (2011)
Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass.
Cell Metab, 14 (3): 365-77. [PMID:21907142]